ASSERTA GLOBAL HEALTHCARE SOLUTIONS

Their core work

Asserta Global Healthcare Solutions is a Spanish private company specializing in healthcare technology and clinical research services for complex, underserved disease areas. Their work spans two complementary domains: digital platforms that connect rare disease patient communities using collective intelligence (SHARE4RARE), and international clinical research coordination in pediatric oncology — specifically childhood leukemia research bridging South American and European medical centers (CLOSER). They bring private-sector agility to large multi-partner consortia that need healthcare systems integration, patient-facing technology, or cross-continental research support. Based near Barcelona in a region dense with pharmaceutical and health technology companies, they function as a specialist bridge between clinical research needs and practical implementation.

What they specialise in

How they've shifted over time

Their early H2020 work (SHARE4RARE, 2018) focused on the digital health space — collective intelligence platforms for rare disease communities, emphasizing patient engagement and networked data-sharing technology. By 2019 they shifted toward clinical and translational research in pediatric oncology through CLOSER, with keywords pointing directly at disease biology (subtypes, childhood leukaemia) and clinical methodology. The trajectory suggests a deliberate move from digital health tooling toward deeper clinical research engagement, though with only two projects this reading remains cautious.

They appear to be deepening into clinical oncology research — specifically pediatric cancers — while retaining a foundation in digital health platforms that connect distributed patient and researcher communities across borders.

How they like to work

Asserta participates exclusively as a consortium partner, never as project coordinator, suggesting they contribute specific expertise rather than drive project strategy. Despite only two projects, they have worked with 21 unique partners across 11 countries, indicating consistent involvement in large, complex multi-partner consortia where specialist contributors play defined delivery roles. This profile suggests they are comfortable operating within international research networks and are best approached for focused, defined contributions rather than consortium leadership.

With 21 unique consortium partners across 11 countries from just two projects, Asserta has a notably broad network relative to its project count. Their CLOSER project's South America–Europe axis suggests active connections in Latin American health research institutions — a rare and valuable asset among Spanish H2020 participants.

What sets them apart

Asserta occupies an uncommon niche: a private Spanish healthcare solutions company combining digital health platform experience with clinical research credentials in pediatric oncology. Their EU–Latin America connectivity through CLOSER sets them apart from purely European research networks, giving them access to patient cohorts and clinical centers that most European partners cannot reach. For consortia needing a private-sector contributor that bridges health informatics and clinical oncology research with a genuinely global reach, they offer a combination few Spanish companies at this scale can match.

Highlights from their portfolio

• CLOSER
  The largest and longest project (2019-2024, EUR 69,125), CLOSER's South America–Europe axis in childhood leukemia research is geographically unusual and demonstrates rare cross-continental clinical research coordination capability.
• SHARE4RARE
  An early foray into collective intelligence for rare disease communities, showing capability in patient-facing digital health platform design within a multi-country EU research context.